Quantitative systems pharmacology (QSP) has emerged as an innovative approach in model-informed drug discovery and development, supporting program decisions from exploratory research through late-stage clinical trials. In this commentary, we discuss the unique value of disease-scale "platform" QSP models that are amenable to reuse and repurposing to support diverse clinical decisions in ways distinct from other pharmacometrics strategies.
No takes yet. Share an insight, caveat, or question.
Musante et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: